New scan could sharpen prostate cancer radiation, spare healthy tissue
NCT ID NCT07393867
Summary
This study is for men with intermediate- or high-risk prostate cancer who are scheduled to receive hormone therapy and radiation. The goal is to see if a special type of imaging scan (PSMA PET/CT), taken during hormone treatment, can help doctors more accurately aim radiation at the remaining cancer while avoiding areas that have already responded well. All participants will receive standard hormone and radiation therapy, plus three imaging scans over six months, to see if this approach makes treatment more precise and potentially reduces side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Dana-Farber/Brigham and Women's Cancer Center at Milford Regional Medical Center
Milford, Massachusetts, 01757, United States
-
Dana-Farber/Brigham and Women's Cancer Center in Clinical Affiliation with South Shore Hospital
Weymouth, Massachusetts, 02190, United States
Conditions
Explore the condition pages connected to this study.